Biotechnology foundations and innovations
From the chemistry of biological building blocks to AI-driven analysis of disease, take a deep dive into the disciplines shaping the future of biotechnology!
- Artificial intelligence and big data
- Chemical and biochemical engineering
- Chemistry and biochemistry
- Cell biology
- DNA technologies
- Metabolic engineering
- Protein technologies
- Synthetic biology
Willard Henry Dow Professor in Chemical Engineering
Massachusetts Institute of Technology
Greg Stephanopoulos biography
Dr. Greg Stephanopoulos is presently the W.H. Dow Professor of Chemical Engineering and Biotechnology at MIT, and Instructor of Bioengineering at Harvard Medical School (1997-). He received his Bachelor of Science from the National Technical University of Athens, his Masters of Science from the University of Florida, and his PhD from the University of Minnesota, all in chemical engineering. He taught at Caltech between 1978-85, after which he was appointed Professor of chemical engineering at MIT.
His current research focuses on metabolic engineering, the engineering of microbes for the production of fuels and chemicals. He is a co-author of the first textbook on metabolic engineering, and currently directs a research group of approximately 25 researchers in this field. He has co-authored or –edited 5 books, more than 425 papers and 50 patents and mentored more than 150 graduate and post-doctoral students. He is the editor-in-chief of Metabolic Engineering and Current Opinion in Biotechnology and serves on the editorial boards of 10 scientific journals and the advisory boards of five chemical engineering departments.
For his research and educational contributions, Dr. Stephanopoulos has received more than 20 major awards including the Eni Prize for Renewable and non-Conventional Energy. He is a member of the National Academy of Engineering and Academy of Athens and currently serves as President of the American Institute of Chemical Engineers.
- Date modified: